In Figs. 1, 2A, 5 of this article, the shadings were not shown; the Figs. 1, 2A, 5 should have appeared as shown in this Correction.

In this article the caption to Fig. 2 was incorrectly given as: “Cumulative proportions of ET prescription after endometrial cancer surgery by age groups. A In the non-adj-group and B adj-group. Shading indicates 95% confidence interval. The 95% confidence intervals in Fig. 1B are described in Supplementary Fig. 2. ET, estrogen therapy”.

The revised caption should read as: “Cumulative proportions of ET prescription after endometrial cancer surgery by age groups. A In the non-adj-group and B adj-group. Shading indicates 95% confidence interval. The 95% confidence intervals in Fig. 2B are described in Supplementary Fig. 2. ET, estrogen therapy”.

The original publication has been corrected.

Cumulative proportions of ET prescription after endometrial cancer surgery. Shading indicates 95% confidence interval. ET estrogen therapy, adj adjuvant therapy group, non-adj non-adjuvant therapy group

Cumulative proportions of ET prescription after endometrial cancer surgery by age groups. A In the non-adj-group and B adj-group. Shading indicates 95% confidence interval. The 95% confidence intervals in Fig. 2B are described in Supplementary Fig. 2. ET, estrogen therapy

Cumulative proportions of ET prescription by patient’s health check-up data. A By BMI, B blood TG levels, C blood LDL levels, and D smoking habits. Shading indicates 95% confidence interval. BMI body mass index, ET estrogen therapy, TG triglyceride, LDL low-density lipoprotein